Advisor Group
VYNT

Advisor Group’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Advisor Group’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-13
Closed -$5K – 5108
2017
Q3 		$5K Sell
13
-17
-57% -$8.86K ﹤0.01% 4299
2017
Q2 		$18K Buy
30
+17
+131% +$9.94K ﹤0.01% 3573
2017
Q1 		$8K Hold
13
– – ﹤0.01% 3925
2016
Q4 		$3K Hold
13
– – ﹤0.01% 4152
2016
Q3 		$4K Sell
13
-2
-13% -$613 ﹤0.01% 4018
2016
Q2 		$3K Buy
+15
New +$5.27K ﹤0.01% 4014

Other funds holding VYNT

SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Granahan Investment Management
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
FCM
Fairbanks Capital Management Rancho Santa Fe, California $169M AUM 12.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
DM
Diker Management New York $130M AUM 97.77% 1-Year Est. Return

Advisor Group's VYNT Position: Q4 2017 in Review

Advisor Group sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q4 2017, closing a stake of 13 shares — an estimated $5K sold.

Advisor Group first reported a position in VYNT in Q2 2016 and held it in 6 quarters. The position peaked at $18K in Q2 2017. 25 funds tracked by Wall St. Rank hold VYNT as of Q4 2017.

  • Advisor Group reported no remaining Vyant Bio, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Advisor Group sold 13 Vyant Bio, Inc. Common Stock shares in Q4 2017, an estimated $5K.
  • Advisor Group first reported a position in Vyant Bio, Inc. Common Stock in Q2 2016 and held it in 6 quarters.
  • Advisor Group's Vyant Bio, Inc. Common Stock position peaked at $18K in Q2 2017.
  • 25 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q4 2017.

Based on Advisor Group's 13F filing for Q4 2017, filed 14 Feb 2018.